P. Robson

发表

Non-peptide oxytocin agonists.

A. Tartar, G. R. Pitt, R. Haigh, 2004, Bioorganic & medicinal chemistry letters.

Nonpeptide oxytocin agonists

A. Tartar, R. Laporte, G. R. Pitt, 2006 .

Intact 5Ht neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline

S. Clements-Jewery, P. Robson, 1982, Neuropharmacology.

Biochemical investigations into the mode of action of trazodone

S. Clements-Jewery, P. Robson, L. Chidley, 1980, Neuropharmacology.

The in vivo and in vitro occupation of [3H]-spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists

S. Clements-Jewery, P. Robson, 1980, Neuropharmacology.

Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles.

D. Kay, S. Matharu, A. C. Barnes, 1988, Journal of medicinal chemistry.

Synthesis and Oral Antiallergic Activity of Carboxylic Acids Derived from Imidazo(2,1-c)(1,4)benzoxazines, Imidazo(1,2-a)quinolines, Imidazo(1,2-a)quinoxalines, Imidazo(1,2-a)quinoxalinones, Pyrrolo(1,2-a)quinoxalinones, Pyrrolo(2,3-a

W. R. Tully, D. Kay, S. Matharu, 1988 .

Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.

R. Williamson, D. Moss, A. Curnock, 1997, The Journal of pharmacology and experimental therapeutics.

Plasma Kallikrein Mediates Vascular Endothelial Growth Factor–Induced Retinal Dysfunction and Thickening

L. Aiello, A. Clermont, E. Feener, 2016, Investigative ophthalmology & visual science.

Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide.

R. Williamson, T. Hercend, J. Bruneau, 1996, Transplantation proceedings.

Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound (*)

P. Morand, R. Williamson, T. Hercend, 1995, The Journal of Biological Chemistry.

Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide.

R. Williamson, J. Bruneau, C. Sautés, 1998, The Biochemical journal.